Tag Archive for: MINDCURE
Psychedelic Business Spotlight – March 18
Business, Stock ReportsThis week in psychedelic business news: A psychedelics company folds; Ketamine Wellness Centers expand; Nova Mentis funds psilocybin studies.
Mind Cure Health Halts All Psychedelic Business Activity
Business, NewsThe company was pursuing several psychedelic business strategies, including synthesizing ibogaine for researchers.
How Psychedelic Treatment Through Canada’s SAP Works
PolicyTwo psychedelic industry insiders reflect on the progress and flaws within Health Canada's recent amendment to the Special Access Program.
Psychedelic Companies HAVN Life Sciences, MINDCURE Health Reach Manufacturing Milestones
BusinessThe global supply chain of regulated psilocybin and ibogaine continues to grow as these Canadian companies beef up manufacturing efforts.